Thyroid Nodules

Medical Clinics of North America

Volumn 96, Issue 2, 2012, Pages 329-349

  Popoveniuc, Geanina ^a,b   Jonklaas, Jacqueline ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Elastography; FNA biopsy; Indeterminate cytology; Malignancy; Molecular markers; Thyroid nodule; TSH; Ultrasonography

Indexed keywords

CALCITONIN; FLUORODEOXYGLUCOSE F 18; IODINE 131; LEVOTHYROXINE; THYROTROPIN;

ASPIRATION; ASPIRATION BIOPSY; ASPIRATION CYTOLOGY; BONE DENSITY; CALCITONIN BLOOD LEVEL; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL EVALUATION; COLOR ULTRASOUND FLOWMETRY; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; ECHOGRAPHY; ELASTOGRAPHY; FOLLOW UP; GENE MUTATION; HEART ATRIUM FIBRILLATION; HUMAN; MEDICAL HISTORY; MULTIPLE ENDOCRINE NEOPLASIA; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SUBTOTAL THYROIDECTOMY; THYROID CANCER; THYROID CYST; THYROID MEDULLARY CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; TOXIC GOITER; TUMOR DIAGNOSIS;

DIAGNOSIS, DIFFERENTIAL; HUMANS; INCIDENTAL FINDINGS; NEOPLASM STAGING; RISK FACTORS; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84858775652     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2012.02.002     Document Type: Review

References (104)

1. Cooper D.S. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009, 19(11):1167-1214.
2. Marqusee E., Benson C.B., Frates M.C., et al. Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med 2000, 133(9):696-700.
3. Singer P.A., Cooper D.S., Daniels G.H., et al. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med 1996, 156(19):2165-2172.
4. Mazzaferri E.L. Management of a solitary thyroid nodule. N Engl J Med 1993, 328(8):553-559.
5. Ezzat S., Sarti D.A., Cain D.R., et al. Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 1994, 154(16):1838-1840.
6. Tan G.H., Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997, 126(3):226-231.
7. Guth S., Theune U., Aberle J., et al. Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Invest 2009, 39(8):699-706.
8. Mortensen J.D., Woolner L.B., Bennett W.A. Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 1955, 15(10):1270-1280.
9. Kung A.W., Chau M.T., Lao T.T., et al. The effect of pregnancy on thyroid nodule formation. J Clin Endocrinol Metab 2002, 87(3):1010-1014.
10. Struve C.W., Haupt S., Ohlen S. Influence of frequency of previous pregnancies on the prevalence of thyroid nodules in women without clinical evidence of thyroid disease. Thyroid 1993, 3(1):7-9.
11. DeGroot L.J. Clinical review 2: diagnostic approach and management of patients exposed to irradiation to the thyroid. J Clin Endocrinol Metab 1989, 69(5):925-928.
12. Antonelli A., Silvano G., Bianchi F., et al. Risk of thyroid nodules in subjects occupationally exposed to radiation: a cross sectional study. Occup Environ Med 1995, 52(8):500-504.
13. Hegedus L. Clinical practice. The thyroid nodule. N Engl J Med 2004, 351(17):1764-1771.
14. Lin J.D., Chao T.C., Huang B.Y., et al. Thyroid cancer in the thyroid nodules evaluated by ultrasonography and fine-needle aspiration cytology. Thyroid 2005, 15(7):708-717.
15. de Matos P.S., Ferreira A.P., Ward L.S. Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series. Endocr Pathol 2006, 17(2):165-173.
16. Kovács G.L., Gonda G., Vadász G., et al. Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake. Thyroid 2005, 15(2):152-157.
17. Pazaitou-Panayiotou K., Capezzone M., Pacini F. Clinical features and therapeutic implication of papillary thyroid microcarcinoma. Thyroid 2007, 17(11):1085-1092.
18. Sugitani I., Toda K., Yamada K., et al. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg 2010, 34(6):1222-1231.
19. Kang K.W., Kim S.K., Kang H.S., et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 2003, 88(9):4100-4104.
20. Hemminki K., Eng C., Chen B. Familial risks for nonmedullary thyroid cancer. J Clin Endocrinol Metab 2005, 90(10):5747-5753.
21. Lloyd K.M., Dennis M. Cowden's disease. A possible new symptom complex with multiple system involvement. Ann Intern Med 1963, 58:136-142.
22. Liaw D., Marsh D.J., Li J., et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997, 16(1):64-67.
23. Carney J.A., Gordon H., Carpenter P.C., et al. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 1985, 64(4):270-283.
24. Gharib H., Papini E., Valcavi R., et al. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 2006, 12(1):63-102.
25. Gharib H., Papini E., Paschke R., et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. J Endocrinol Invest 2010, 33(Suppl 5):51-56.
26. Fiore E., Rago T., Provenzale M.A., et al. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocr Relat Cancer 2009, 16(4):1251-1260.
27. Meller J., Becker W. The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound. Eur J Nucl Med Mol Imaging 2002, 29(Suppl 2):S425-S438.
28. Boelaert K., Horacek J., Holder R.L., et al. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 2006, 91(11):4295-4301.
29. Haymart M.R., Glinberg S.L., Liu J., et al. Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension. Clin Endocrinol (Oxf) 2009, 71(3):434-439.
30. Haymart M.R., Repplinger D.J., Leverson G.E., et al. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 2008, 93(3):809-814.
31. Jonklaas J., Nsouli-Maktabi H., Soldin S.J. Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer. Thyroid 2008, 18(9):943-952.
32. Jimenez C., Hu M.I., Gagel R.F. Management of medullary thyroid carcinoma. Endocrinol Metab Clin North Am 2008, 37(2):481-496. x-xi.
33. Hahm J.R., Lee M.S., Min Y.K., et al. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Thyroid 2001, 11(1):73-80.
34. Cheung K., Roman S.A., Wang T.S., et al. Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis. J Clin Endocrinol Metab 2008, 93(6):2173-2180.
35. Gharib H., Papini E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am 2007, 36(3):707-735. vi.
36. Frates M.C., Benson C.B., Charboneau J.W., et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology 2005, 237(3):794-800.
37. Mandel S.J. Diagnostic use of ultrasonography in patients with nodular thyroid disease. Endocr Pract 2004, 10(3):246-252.
38. Papini E., Guglielmi R., Bianchini A., et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002, 87(5):1941-1946.
39. Rago T., Vitti P., Chiovato L., et al. Role of conventional ultrasonography and color flow-Doppler sonography in predicting malignancy in 'cold' thyroid nodules. Eur J Endocrinol 1998, 138(1):41-46.
40. Hong Y.J., Son E.J., Kim E.K., et al. Positive predictive values of sonographic features of solid thyroid nodule. Clin Imaging 2010, 34(2):127-133.
41. Moon W.J., Jung S.L., Lee J.H., et al. Benign and malignant thyroid nodules: US differentiation-multicenter retrospective study. Radiology 2008, 247(3):762-770.
42. Frasoldati A., Valcavi R. Challenges in neck ultrasonography: lymphadenopathy and parathyroid glands. Endocr Pract 2004, 10(3):261-268.
43. Papini E. The dilemma of non-palpable thyroid nodules. J Endocrinol Invest 2003, 26(1):3-4.
44. Frates MC, Benson CB, Doubilet PM, et al. Likelihood of thyroid cancer based on sonographic assessment of nodule size and composition [abstract]. In: Radiological Society of North America Scientific Assembly and Annual Meeting Program. Oak Brook (IL): Radiological Society of North America; 2004. p. 395.
45. Kim E.K., Park C.S., Chung W.Y., et al. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AJR Am J Roentgenol 2002, 178(3):687-691.
46. Baskin H.J. Thyroid ultrasound and ultrasound-guided FNA biopsy. Ultrasound of thyroid nodules 2000, 71-86. Kluwer Academic Publishers, Boston. H.J. Baskin (Ed.).
47. Ueno E., Ito A. Diagnosis of breast cancer by elasticity imaging. Eizo Joho Medical 2004, 36:2-6.
48. Rago T., Santini F., Scutari M., et al. Elastography: new developments in ultrasound for predicting malignancy in thyroid nodules. J Clin Endocrinol Metab 2007, 92(8):2917-2922.
49. Bojunga J., Herrmann E., Meyer G., et al. Real-time elastography for the differentiation of benign and malignant thyroid nodules: a meta-analysis. Thyroid 2010, 20(10):1145-1150.
50. Rago T., Scutari M., Santini F., et al. Real-time elastosonography: useful tool for refining the presurgical diagnosis in thyroid nodules with indeterminate or nondiagnostic cytology. J Clin Endocrinol Metab 2010, 95(12):5274-5280.
51. Rago T., Vitti P. Role of thyroid ultrasound in the diagnostic evaluation of thyroid nodules. Best Pract Res Clin Endocrinol Metab 2008, 22(6):913-928.
52. Castro M.R., Gharib H. Thyroid fine-needle aspiration biopsy: progress, practice, and pitfalls. Endocr Pract 2003, 9(2):128-136.
53. Gharib H., Goellner J.R. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 1993, 118(4):282-289.
54. Danese D., Sciacchitano S., Farsetti A., et al. Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules. Thyroid 1998, 8(1):15-21.
55. Fraker D.L. Thyroid tumors. Cancer: principles and practice of oncology 1997, 1629-1652. Lippincott-Raven, Philadelphia. V. HS De Vita, S. Rosenberg (Eds.).
56. Baloch Z.W., Tam D., Langer J., et al. Ultrasound-guided fine-needle aspiration biopsy of the thyroid: role of on-site assessment and multiple cytologic preparations. Diagn Cytopathol 2000, 23(6):425-429.
57. Braga M., Cavalcanti T.C., Collaço L.M., et al. Efficacy of ultrasound-guided fine-needle aspiration biopsy in the diagnosis of complex thyroid nodules. J Clin Endocrinol Metab 2001, 86(9):4089-4091.
58. Yeh M.W., Demircan O., Ituarte P., et al. False-negative fine-needle aspiration cytology results delay treatment and adversely affect outcome in patients with thyroid carcinoma. Thyroid 2004, 14(3):207-215.
59. Baloch Z.W., LiVolsi V.A., Asa S.L., et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 2008, 36(6):425-437.
60. Gharib H., Goellner J.R. Fine-needle aspiration biopsy of thyroid nodules. Endocr Pract 1995, 1(6):410-417.
61. Meko J.B., Norton J.A. Large cystic/solid thyroid nodules: a potential false-negative fine-needle aspiration. Surgery 1995, 118(6):996-1003. [discussion: 1003-4].
62. Baloch Z.W., Fleisher S., LiVolsi V.A., et al. Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 2002, 26(1):41-44.
63. Nikiforov Y.E., Steward D.L., Robinson-Smith T.M., et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 2009, 94(6):2092-2098.
64. Franco C., Martínez V., Allamand J.P., et al. Molecular markers in thyroid fine-needle aspiration biopsy: a prospective study. Appl Immunohistochem Mol Morphol 2009, 17(3):211-215.
65. Kim S.K., Hwang T.S., Yoo Y.B., et al. Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status. J Clin Endocrinol Metab 2011, 96(3):658-664.
66. Nikiforov Y.E., Ohori N.P., Hodak S.P., et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 2011, 96(11):3390-3397.
67. Li H., Robinson K.A., Anton B., et al. Cost-effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules. J Clin Endocrinol Metab 2011, 96(11):E1719-E1726.
68. Chudova D., Wilde J.I., Wang E.T., et al. Molecular classification of thyroid nodules using high-dimensionality genomic data. J Clin Endocrinol Metab 2010, 95(12):5296-5304.
69. Bartolazzi A., Gasbarri A., Papotti M., et al. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 2001, 357(9269):1644-1650.
70. Bartolazzi A., Orlandi F., Saggiorato E., et al. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol 2008, 9(6):543-549.
71. Weber K.B., Shroyer K.R., Heinz D.E., et al. The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer. Am J Clin Pathol 2004, 122(4):524-531.
72. Milas M., Shin J., Gupta M., et al. Circulating thyrotropin receptor mRNA as a novel marker of thyroid cancer: clinical applications learned from 1758 samples. Ann Surg 2010, 252(4):643-651.
73. Giovanella L., Suriano S., Maffioli M., et al. 18FDG-positron emission tomography/computed tomography (PET/CT) scanning in thyroid nodules with nondiagnostic cytology. Clin Endocrinol (Oxf) 2011, 74(5):644-648.
74. Sebastianes F.M., Cerci J.J., Zanoni P.H., et al. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules. J Clin Endocrinol Metab 2007, 92(11):4485-4488.
75. de Geus-Oei L.F., Pieters G.F., Bonenkamp J.J., et al. 18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results. J Nucl Med 2006, 47(5):770-775.
76. Kresnik E., Gallowitsch H.J., Mikosch P., et al. Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery 2003, 133(3):294-299.
77. Frates M.C., Benson C.B., Doubilet P.M., et al. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab 2006, 91(9):3411-3417.
78. Lazarus J.H. Guidelines for the use of radioiodine in the management of hyperthyroidism: a summary. Prepared by the Radioiodine Audit Subcommittee of the Royal College of Physicians Committee on Diabetes and Endocrinology, and the Research Unit of the Royal College of Physicians. J R Coll Physicians Lond 1995, 29(6):464-469.
79. Bennedbaek F.N., Hegedus L. Treatment of recurrent thyroid cysts with ethanol: a randomized double-blind controlled trial. J Clin Endocrinol Metab 2003, 88(12):5773-5777.
80. Valcavi R., Frasoldati A. Ultrasound-guided percutaneous ethanol injection therapy in thyroid cystic nodules. Endocr Pract 2004, 10(3):269-275.
81. Tarantino L., Francica G., Sordelli I., et al. Percutaneous ethanol injection of hyperfunctioning thyroid nodules: long-term follow-up in 125 patients. AJR Am J Roentgenol 2008, 190(3):800-808.
82. Papini E., Panunzi C., Pacella C.M., et al. Percutaneous ultrasound-guided ethanol injection: a new treatment of toxic autonomously functioning thyroid nodules?. J Clin Endocrinol Metab 1993, 76(2):411-416.
83. Lippi F., Manetti L., Rago T. Percutaneous ultrasound-guided ethanol injection for treatment of autonomous thyroid nodules: results of a multicentric study. J Endocrinol Invest 1994, 17(Suppl 2):71. [abstract].
84. Verde G., Papini E., Pacella C.M., et al. Ultrasound guided percutaneous ethanol injection in the treatment of cystic thyroid nodules. Clin Endocrinol (Oxf) 1994, 41(6):719-724.
85. Castro M.R., Caraballo P.J., Morris J.C. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab 2002, 87(9):4154-4159.
86. Papini E., Bacci V., Panunzi C., et al. A prospective randomized trial of levothyroxine suppressive therapy for solitary thyroid nodules. Clin Endocrinol (Oxf) 1993, 38(5):507-513.
87. Papini E., Petrucci L., Guglielmi R., et al. Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 1998, 83(3):780-783.
88. Wemeau J.L., Caron P., Schvartz C., et al. Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group. J Clin Endocrinol Metab 2002, 87(11):4928-4934.
89. Zelmanovitz F., Genro S., Gross J.L. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. J Clin Endocrinol Metab 1998, 83(11):3881-3885.
90. La Rosa G.L., Ippolito A.M., Lupo L., et al. Cold thyroid nodule reduction with L-thyroxine can be predicted by initial nodule volume and cytological characteristics. J Clin Endocrinol Metab 1996, 81(12):4385-4387.
91. Parle J.V., Maisonneuve P., Sheppard M.C., et al. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001, 358(9285):861-865.
92. Fiore E., Rago T., Provenzale M.A., et al. L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients. Endocr Relat Cancer 2010, 17(1):231-239.
93. Carmeci C., Jeffrey R.B., McDougall I.R., et al. Ultrasound-guided fine-needle aspiration biopsy of thyroid masses. Thyroid 1998, 8(4):283-289.
94. Tan G.H., Gharib H., Reading C.C. Solitary thyroid nodule. Comparison between palpation and ultrasonography. Arch Intern Med 1995, 155(22):2418-2423.
95. Brauer V.F., Eder P., Miehle K., et al. Interobserver variation for ultrasound determination of thyroid nodule volumes. Thyroid 2005, 15(10):1169-1175.
96. Asanuma K., Kobayashi S., Shingu K., et al. The rate of tumour growth does not distinguish between malignant and benign thyroid nodules. Eur J Surg 2001, 167(2):102-105.
97. Oertel Y.C., Miyahara-Felipe L., Mendoza M.G., et al. Value of repeated fine needle aspirations of the thyroid: an analysis of over ten thousand FNAs. Thyroid 2007, 17(11):1061-1066.
98. Tan G.H., Gharib H., Goellner J.R., et al. Management of thyroid nodules in pregnancy. Arch Intern Med 1996, 156(20):2317-2320.
99. Morris D.M., Herzon F.S., Segal M.N., et al. Coexistent thyroid cancer and pregnancy. Arch Otolaryngol Head Neck Surg 1994, 120(11):1191-1193.
100. Moosa M., Mazzaferri E.L. Outcome of differentiated thyroid cancer diagnosed in pregnant women. J Clin Endocrinol Metab 1997, 82(9):2862-2866.
101. Kuy S., Roman S.A., Desai R., et al. Outcomes following thyroid and parathyroid surgery in pregnant women. Arch Surg 2009, 144(5):399-406. [discussion: 406].
102. Mazzaferri E.L., Jhiang S.M. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994, 97(5):418-428.
103. Mestman J.H., Goodwin T.M., Montoro M.M. Thyroid disorders of pregnancy. Endocrinol Metab Clin North Am 1995, 24(1):41-71.
104. Rosen I.B., Korman M., Walfish P.G. Thyroid nodular disease in pregnancy: current diagnosis and management. Clin Obstet Gynecol 1997, 40(1):81-89.